Cargando…

Bayesian modelling of response to therapy and drug-sensitivity in acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is a heterogeneous haematologic malignancy involving the abnormal proliferation of immature lymphocytes and accounts for most paediatric cancer cases. The management of ALL in children has seen great improvement in the last decades thanks to greater understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cremaschi, Andrea, Yang, Wenjian, De Iorio, Maria, Evans, William E., Yang, Jun J., Rosner, Gary L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980194/ https://www.ncbi.nlm.nih.gov/pubmed/36865272 http://dx.doi.org/10.21203/rs.3.rs-2542277/v1

Ejemplares similares

Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells
por: Rowland, Lauren, et al.
Publicado: (2023)

Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
por: Lee, Shawn H. R., et al.
Publicado: (2023)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
por: Karol, Seth E., et al.
Publicado: (2021)

Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2017)

Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia
por: Yang, Wenjian, et al.
Publicado: (2022)

Bayesian clustering of multiple zero-inflated outcomes
por: Franzolini, Beatrice, et al.
Publicado: (2023)

Improving the treatment of childhood acute lymphoblastic leukemia by optimizing the use of 70-year-old drugs
por: Evans, William E.
Publicado: (2021)

Sensitivity to Pain in Children With Acute Lymphoblastic Leukemia (ALL)
por: Firoozi, Manijeh, et al.
Publicado: (2012)

In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile
por: Sorich, Michael J, et al.
Publicado: (2008)

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy
por: Slone, William L., et al.
Publicado: (2016)

Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations
por: Toksvang, Linea N., et al.
Publicado: (2022)

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
por: Yu, M, et al.
Publicado: (2011)

Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab
por: Hladnik,1, Lindsay, et al.
Publicado: (2016)

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019)

Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)

CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia
por: GUO, WENJIAN, et al.
Publicado: (2014)

Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist
por: Parameswaran, Reshmi, et al.
Publicado: (2011)

A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia
por: Bainer, Russell O, et al.
Publicado: (2017)

Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence
por: Luong, Annie, et al.
Publicado: (2021)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Association between CEP72 genotype and persistent neuropathy in survivors of childhood acute lymphoblastic leukemia
por: Goodenough, Chelsea G., et al.
Publicado: (2022)

Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia
por: Bergeron, Brennan P., et al.
Publicado: (2022)

Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance
por: Lautner-Csorba, Orsolya, et al.
Publicado: (2012)

Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia
por: Jiang, Chuang, et al.
Publicado: (2022)

Recent updates for antibody therapy for acute lymphoblastic leukemia
por: Li, Le, et al.
Publicado: (2020)

Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
por: Ferguson, Daniel C., et al.
Publicado: (2022)

Towards personalized chemotherapy of acute lymphoblastic leukemia
por: Hnízda, Aleš, et al.
Publicado: (2018)

Application of Glutamine-enriched nutrition therapy in childhood acute lymphoblastic leukemia
por: Han, Yueqin, et al.
Publicado: (2016)

A Bayesian nonparametric approach to dynamic item‐response modeling: An application to the GUSTO cohort study
por: Cremaschi, Andrea, et al.
Publicado: (2021)

International Collaboration to Save Children With Acute Lymphoblastic Leukemia
por: Pui, Ching-Hon, et al.
Publicado: (2019)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Predicting Drug Response in Acute Lymphoblastic Leukemia: Highlights From SOHO 2020
Publicado: (2021)

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists
por: Bai, Ling, et al.
Publicado: (2023)

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia
por: Escherich, Carolin, et al.
Publicado: (2022)

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children
por: Escherich, Carolin, et al.
Publicado: (2023)

bayesynergy: flexible Bayesian modelling of synergistic interaction effects in in vitro drug combination experiments
por: Rønneberg, Leiv, et al.
Publicado: (2021)

Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia
por: Lorentzian, Amanda C., et al.
Publicado: (2023)

Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
por: Zhang, Ziting, et al.
Publicado: (2022)

Multilocus Genotypes of Relevance for Drug Metabolizing Enzymes and Therapy with Thiopurines in Patients with Acute Lymphoblastic Leukemia
por: Stocco, Gabriele, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8bkec2fnoqql0jadr5s218u039